Furthermore, pre-treatment of SH-SY5Y and SK-N-SH cells with KYNA was shown to reduce the 1-methyl-4-phenylpyridinium-induced neuronal cell death through the attenuation of caspase-9/-3 activities in an in vitro model of Parkinson’s disease [49]. This evidence concerns the gene CASP9 and Parkinson disease.